These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 63952)

  • 1. Human alpha-fetoprotein as a modulator of human lymphocyte transformation: correlation of biological potency with electrophoretic variants.
    Lester EP; Miller JB; Yachnin S
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4645-8. PubMed ID: 63952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A postsynthetic modification of human alpha-fetoprotein controls its immunosuppressive potency.
    Lester EP; Miller JB; Yachnin S
    Proc Natl Acad Sci U S A; 1977 Sep; 74(9):3988-92. PubMed ID: 71737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of the inhibitory effect of human alpha-fetoprotein on in vitro transformation of human lymphocytes.
    Yachnin S
    Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2857-61. PubMed ID: 60761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human lymphocyte transformation by human alpha-fetoprotein (HAFP); HAFP monomers and multimers and a resistant lymphocyte subpopulation.
    Yachnin S; Lester EP
    J Immunol; 1977 Aug; 119(2):555-7. PubMed ID: 69662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human alpha-fetoprotein: immunosuppressive activity and microheterogeneity.
    Lester EP; Miller JB; Yachnin S
    Immunol Commun; 1978; 7(2):137-61. PubMed ID: 77248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human lymphocyte transformation by human alpha-foetoprotein (HAFP); comparison of foetal and hepatoma HAFP and kinetic studies in vitro immunosuppression.
    Yachnin S; Lester E
    Clin Exp Immunol; 1976 Dec; 26(3):484-90. PubMed ID: 64327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid interactions with human alpha-fetoprotein (AFP). A study of the role of such interactions in the ability of human AFP to suppress lymphocyte transformation.
    Yachnin S; Getz GS; Lusk L; Hsu RC
    Oncodev Biol Med; 1980; 1(4-5):273-85. PubMed ID: 6169064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human lymphocyte transformation by human alpha-foetoprotein (HAFP): studies on the mode of HAFP action and the role of HAFP polymorphism.
    Lester EP; Miller JB; Baron JM; Yachnin S
    Immunology; 1978 Feb; 34(2):189-98. PubMed ID: 75181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of alpha-fetoprotein from the mouse hepatoma BW7756.
    Allen RP; Mizejewski GJ
    Biochim Biophys Acta; 1977 Mar; 491(1):242-52. PubMed ID: 66068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on human alpha-fetoprotein. Isolation and characterization of monomeric and polymeric forms and amino-terminal sequence analysis.
    Yachnin S; Hsu R; Heinrikson RL; Miller JB
    Biochim Biophys Acta; 1977 Aug; 493(2):418-28. PubMed ID: 70228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of human alpha-fetoprotein as revealed by isoelectric focusing in urea-containing gels.
    Lester EP; Miller JB; Yachnin S
    Biochim Biophys Acta; 1978 Sep; 536(1):165-71. PubMed ID: 81690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of lymphocyte proliferation by sera from patients with hepatocellular carcinoma: lack of correlation with serum alpha-fetoprotein levels.
    Ren EC; Chan SH
    J Natl Cancer Inst; 1981 Apr; 66(4):625-30. PubMed ID: 6164810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental microheterogeneity of mouse alpha-fetoproteins: purification and partial characterization.
    Zimmerman EF; Bowen D; Wilson JR; Madappally MM
    Biochemistry; 1976 Dec; 15(25):5534-43. PubMed ID: 63288
    [No Abstract]   [Full Text] [Related]  

  • 14. Microheterogeneity of rat alpha-fetoprotein.
    Watanabe A; Taketa K; Kosaka K
    Ann N Y Acad Sci; 1975 Aug; 259():95-108. PubMed ID: 54043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and immunochemical characterization of alpha-fetoprotein from rat fetal serum and liver.
    Watanabe A; Mori O; Taketa K; Kosaka K
    Acta Med Okayama; 1975 Oct; 29(5):355-66. PubMed ID: 58541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical approach to the purification of human alpha1-fetoprotein from the ascites fluid of a hepatoma-bearing patient.
    Gold P; Labitan A; Wong HC; Freedman SO; Krupey J; Shuster J
    Cancer Res; 1978 Jan; 38(1):6-12. PubMed ID: 73414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical characterization of bovine alpha-fetoprotein and comparison with human alpha-fetoprotein.
    He Y; Keel BA
    Comp Biochem Physiol Biochem Mol Biol; 1994 Jul; 108(3):327-36. PubMed ID: 7521727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human fetal and tumor alpha-fetoproteins differ in conformationally dependent epitope variants expression.
    Yazova AK; Goussev AI; Christiansen M; Kushlinsky NE; Stogova E; Norgaard-Pedersen B; Abelev GI
    Immunol Lett; 2003 Feb; 85(3):261-70. PubMed ID: 12663141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of a distinct immunoregulatory isoform of alpha-fetoprotein produced by the normal fetus.
    van Oers NS; Cohen BL; Murgita RA
    J Exp Med; 1989 Sep; 170(3):811-25. PubMed ID: 2475575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative chemical structures of human alpha-fetoproteins from fetal serum and from ascites fluid of a patient with hepatoma.
    Aoyagi Y; Ikenaka T; Ichida F
    Cancer Res; 1977 Oct; 37(10):3663-7. PubMed ID: 71198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.